Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -46.59% is 19% below its 5-year average of -39.17%, near the high end of its 5-year range (-248.17%–-22.70%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.36% below its 12-month average of -43.80%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -46.59%.
RETURN ON INVESTED CAPITAL (ROIC)
-46.59%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-43.80%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-37.63%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-39.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-6.36%
CURRENT VS 3Y AVG
-23.82%
CURRENT VS 5Y AVG
-18.95%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.17%
median of 543 covered companies
CURRENT VS SECTOR MEDIAN
-49.47%
vs the sector median at left
Compass Therapeutics, Inc.
Market Cap
$177.22M
Return on Invested Capital (ROIC)
-46.59%
TTM Avg
-43.80%
3Y Avg
-37.63%
5Y Avg
-39.17%
Market Cap
$178.56M
Return on Invested Capital (ROIC)
-1039.56%
TTM Avg
-137.05%
3Y Avg
-111.74%
5Y Avg
-93.55%
Market Cap
$173.89M
Return on Invested Capital (ROIC)
-30.23%
TTM Avg
-28.70%
3Y Avg
-31.34%
5Y Avg
-41.69%
Market Cap
$172.65M
Return on Invested Capital (ROIC)
-58.55%
TTM Avg
-41.33%
3Y Avg
-32.67%
5Y Avg
-48.97%
Market Cap
$179.31M
Return on Invested Capital (ROIC)
-9.57%
TTM Avg
-477.38%
3Y Avg
-295.61%
5Y Avg
-295.61%
Market Cap
$182.88M
Return on Invested Capital (ROIC)
-5.22%
TTM Avg
-22.12%
3Y Avg
-29.09%
5Y Avg
-27.39%
Market Cap
$165.46M
Return on Invested Capital (ROIC)
-135.38%
TTM Avg
-110.80%
3Y Avg
-91.23%
5Y Avg
-65.73%
Market Cap
$191.97M
Return on Invested Capital (ROIC)
-51.01%
TTM Avg
-69.12%
3Y Avg
-59.60%
5Y Avg
-89.29%
Market Cap
$159.74M
Return on Invested Capital (ROIC)
-13.94%
TTM Avg
-16.11%
3Y Avg
-25.11%
5Y Avg
-17.04%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | $177.22M | -46.59% | -43.80% | -37.63% | -39.17% |
| Cue Biopharma, Inc. (CUE)vs › | $178.56M | -1039.56% | -137.05% | -111.74% | -93.55% |
| Precision BioSciences, Inc. (DTIL)vs › | $173.89M | -30.23% | -28.70% | -31.34% | -41.69% |
| MediWound Ltd. (MDWD)vs › | $172.65M | -58.55% | -41.33% | -32.67% | -48.97% |
| Canton Strategic Holdings Inc (CNTN)vs › | $179.31M | -9.57% | -477.38% | -295.61% | -295.61% |
| Journey Medical Corporation (DERM)vs › | $182.88M | -5.22% | -22.12% | -29.09% | -27.39% |
| Coherus Oncology, Inc. (CHRS)vs › | $165.46M | -135.38% | -110.80% | -91.23% | -65.73% |
| AN2 Therapeutics, Inc. (ANTX)vs › | $191.97M | -51.01% | -69.12% | -59.60% | -89.29% |
| Inogen, Inc. (INGN)vs › | $159.74M | -13.94% | -16.11% | -25.11% | -17.04% |
| ALX Oncology Holdings Inc. (ALXO)vs › | $160.80M | -56.53% | -185.89% | -125.01% | -88.85% |
ROIC
-46.6%
ROE
-44.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -46.59% |
| 2026-03-31 | -38.57% |
| 2025-12-31 | -35.42% |
| 2025-09-30 | -32.64% |
| 2025-06-30 | -65.80% |
| 2025-03-31 | -53.04% |
| 2024-12-31 | -43.05% |
| 2024-09-30 | -38.31% |
| 2024-06-30 | -37.74% |
| 2024-03-31 | -33.98% |
| 2023-12-31 | -33.79% |
| 2023-09-30 | -29.74% |
| 2023-06-30 | -28.64% |
| 2023-03-31 | -24.99% |
| 2022-12-31 | -22.70% |
| 2022-09-30 | -35.32% |
| 2022-06-30 | -27.07% |
| 2022-03-31 | -59.55% |
| 2021-12-31 | -57.21% |
| 2021-09-30 | -248.17% |
| 2021-06-30 | -209.87% |
| 2021-03-31 | -65.41% |
| 2020-12-31 | -56.44% |
| 2020-09-30 | -44.91% |
| 2020-06-30 | -38.75% |
| 2020-03-31 | -140.68% |
| 2019-12-31 | -130.29% |
